Share this Page:
The MD Anderson Cancer Center (MDACC) 13th Update on the Management of Genitourinary Malignancies Conference took place in Houston, Texas at the end of last week (9-10 November). Kidney cancer highlights from the meeting have been published by UroToday. You can read more online on UroToday below:
MDACC 2018: Promising Emerging Systemic Therapies for mRCC
MDACC 2018: Debate: Is There Still a Role for Cytoreductive Nephrectomy in the Setting of Metastatic Renal Cell Carcinoma?
MDACC 2018: Debate: What is the Best Salvage Therapy After Failure of Immune Checkpoint Inhibition?
MDACC 2018: Debate: What is the Best Front-Line Systemic Therapy for Metastatic Clear Cell Renal Cell Carcinoma?
MDACC 2018: The Evolving Role of Epigenetics in Renal Cell Carcinoma
MDACC 2018: Management of Venous Involvement in Locally Advanced Renal Cell Carcinoma
MDACC 2018: Debate: Adjuvant Therapy for Locally Advanced Renal Cell Carcinoma: Is it Ready for Prime Time?
MDACC 2018: Debate: What is the Role of Biopsy in the Management of the Small Renal Mass?
MDACC 2018: Where Do We Stand with Genetic Screening for Familial Syndromes of RCC and Optimal Management of Patients with VHL?